Form 483

Dr. Rath International, Inc. Form 483, 2013-05-21

FDA issued a Form 483 to Dr. Rath International, Inc. on 2013-05-21 with 9 public-safe observations.

483· Form 483 issuedFoods & Cosmetics9 observations

Dr. Rath International, Inc. · San Jose, United States · Issued May 21, 2013

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 May 2013
21 CFR 111.20(c)(2)

Physical plant - material review and disposition

Cited by Jeanmaire Hryshko, Ronald P Boyce

21 May 2013
21 CFR 111.55

Production, process controls - implement

Cited by Jeanmaire Hryshko, Ronald P Boyce

21 May 2013
21 CFR 111.65

Quality control - quality, dietary supplement

Cited by Jeanmaire Hryshko, Ronald P Boyce

21 May 2013
21 CFR 111.73

Specifications met - received product identified

Cited by Jeanmaire Hryshko, Ronald P Boyce

21 May 2013
21 CFR 111.127

Quality control operations - packaging, labeling

Cited by Jeanmaire Hryshko, Ronald P Boyce

Inspected site

DRDr. Rath International, Inc.San Jose, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.127Cited across public-safe Form 483 observations1x
21 CFR 111.20(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(a)Cited across public-safe Form 483 observations1x
21 CFR 111.535(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.55Cited across public-safe Form 483 observations1x
21 CFR 111.553Cited across public-safe Form 483 observations1x
21 CFR 111.65Cited across public-safe Form 483 observations1x
21 CFR 111.73Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere